Clopidogrel and atorvastatin - Significant drug-drug interactions are seen

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:56GG / 56HH
页数:2
相关论文
共 50 条
  • [41] Drug-drug interactions with raltegravir
    Burger D.M.
    European Journal of Medical Research, 14 (Suppl 3) : 17 - 21
  • [42] Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants
    McCrea, Jacqueline B.
    Menzel, Karsten
    Adedoyin, Adedayo
    Cho, Carolyn R.
    Fox-Bosetti, Sabrina
    Macha, Sreeraj
    Zhao, Tian
    Liu, Fang
    Panebianco, Deborah
    Stoch, S. Aubrey
    Iwamoto, Marian
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (04): : 420 - 428
  • [43] Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat
    Intert, E.
    Krause, M.
    Hennersdorf, F.
    Knop, K.
    Rosenkranz, T.
    INNERE MEDIZIN, 2022, 63 (11): : 1189 - 1193
  • [44] Evaluation of the potential drug-drug interactions of carotegrast methyl with midazolam, prednisolone or atorvastatin in healthy adults
    Matsuki, Shunji
    Oikawa, Ichiro
    Koyama, Tetsuya
    Imai, Hiromitsu
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 871 - 881
  • [45] Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions
    Vildhede, Anna
    Karlgren, Maria
    Svedberg, Elin K.
    Wisniewski, Jacek R.
    Lai, Yurong
    Noren, Agneta
    Artursson, Per
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) : 1210 - 1218
  • [46] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
  • [47] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [48] Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4
    Denisov, Ilia G.
    Baylon, Javier L.
    Grinkova, Yelena V.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2018, 57 (05) : 805 - 816
  • [49] Epidemiology of CYP3A4-Mediated Clopidogrel Drug-Drug Interactions and Their Clinical Consequences
    Tirkkonen, Tuire
    Heikkila, Pekka
    Vahlberg, Tero
    Huupponen, Risto
    Laine, Kari
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (06) : 344 - 351
  • [50] Adverse drug reactions related to drug-drug interactions: lower severity level of drug-drug interactions and pharmacodynamic interactions are oversighted
    Kheloufi, F.
    Duval, M.
    Rouby, F.
    Ponte, J.
    Blin, O.
    Default, A.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89